Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Caputo

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Journal of the American College of Cardiology|November 5, 2017
3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III TrialDean J Kereiakes, Stephen G Ellis, Christopher Metzger, et al.
The New England Journal of Medicine|October 13, 2015
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery DiseaseStephen G Ellis, Dean J Kereiakes, D Christopher Metzger, et al.
Circulation|July 23, 2003
Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass graftsGregg W Stone, Campbell Rogers, James Hermiller, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 12, 2026
Cost-effectiveness analysis of artificial intelligence (AI) for response prediction of neoadjuvant radio(chemo)therapy in locally advanced rectal cancer (LARC) in the NetherlandsL Maas, C Contreras-Meca, S Ghezzo, et al.
Circulation|September 26, 2019
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III TrialDean J Kereiakes, Stephen G Ellis, D Christopher Metzger, et al.
American Heart Journal|March 29, 2008
Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis eventsMichael J Rinaldi, Ajay J Kirtane, Robert N Piana, et al.
American Heart Journal|March 30, 2006
Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trialAmir Halkin, A Zaki Masud, Campbell Rogers, et al.
The American Journal of Cardiology|November 28, 2006
Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial)Atsushi Hirohata, Yoshihiro Morino, Junya Ako, et al.
Journal of the American College of Cardiology|February 16, 2010
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trialMartin B Leon, Laura Mauri, Jeffrey J Popma, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Adopting Best Practices in the Management of Coronary CalcificationLuiz F Ybarra, Michael J Lim, Suzanne J Baron, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Journal of the American College of Cardiology|November 5, 2017
3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III TrialDean J Kereiakes, Stephen G Ellis, Christopher Metzger, et al.
The New England Journal of Medicine|October 13, 2015
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery DiseaseStephen G Ellis, Dean J Kereiakes, D Christopher Metzger, et al.
Circulation|July 23, 2003
Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass graftsGregg W Stone, Campbell Rogers, James Hermiller, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 12, 2026
Cost-effectiveness analysis of artificial intelligence (AI) for response prediction of neoadjuvant radio(chemo)therapy in locally advanced rectal cancer (LARC) in the NetherlandsL Maas, C Contreras-Meca, S Ghezzo, et al.
Circulation|September 26, 2019
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III TrialDean J Kereiakes, Stephen G Ellis, D Christopher Metzger, et al.
American Heart Journal|March 29, 2008
Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis eventsMichael J Rinaldi, Ajay J Kirtane, Robert N Piana, et al.
American Heart Journal|March 30, 2006
Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trialAmir Halkin, A Zaki Masud, Campbell Rogers, et al.
The American Journal of Cardiology|November 28, 2006
Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial)Atsushi Hirohata, Yoshihiro Morino, Junya Ako, et al.
Journal of the American College of Cardiology|February 16, 2010
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trialMartin B Leon, Laura Mauri, Jeffrey J Popma, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Adopting Best Practices in the Management of Coronary CalcificationLuiz F Ybarra, Michael J Lim, Suzanne J Baron, et al.
Pageof 13